MedPath

Effects of consumption of the test food on the halitosis in healthy Japanese subjects

Not Applicable
Conditions
Healthy Japanese subjects
Registration Number
JPRN-UMIN000046201
Lead Sponsor
ORTHOMEDICO Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 5. Subjects who regularly use antimicrobial drugs 6. Subjects currently taking medicines (include herbal medicines) and supplements 7. Subjects who are allergic to medications and/or the test-food-related products 8. Subjects who regularly use mouthwashes 9. Subjects who use artificial tooth, post crowns, dentures, implants, and bridges 10. Subjects who have receiving dental maintenance care at dental clinic, such as removing dental plaques and dental tartars within the last three months 11. Subjects who have a medical history, current illness, or are suspected to be a Sjogren's syndrome 12. Subjects who suffer from disorders associated with salivary gland such as dry mouse and salivary stone disease 13. Subjects who are being treated periodontosis or dental caries 14. Subjects whose salivary secretion volume at rest is less than 1.0 g/10 min 15. Subjects who are smokers 16. Subjects who are pregnant, breast-feeding, and planning to become pregnant 17. Subjects who suffer from COVID-19 18. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 19. Subjects who are judged as ineligible to participate in the study by the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath